Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF-mobilized PB-MNC for Intermittent Claudication
NCT03683628Unknown
- Sponsor
- Mahidol University
- Start
- Oct 2018
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous peripheral blood mononuclear cells (Mahidol University) in intermittent claudication (IC), sponsored by Mahidol University. Primary endpoint: Pain free walking distance at 3 months. Status: unknown.
02
Drugs
autologous peripheral blood mononuclear cells (Mahidol University)
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT03683628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683628.